EP1708674B1 - Antiperspirant aerosol composition - Google Patents
Antiperspirant aerosol composition Download PDFInfo
- Publication number
- EP1708674B1 EP1708674B1 EP05712381.2A EP05712381A EP1708674B1 EP 1708674 B1 EP1708674 B1 EP 1708674B1 EP 05712381 A EP05712381 A EP 05712381A EP 1708674 B1 EP1708674 B1 EP 1708674B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- aerosol composition
- antiperspirant aerosol
- antiperspirant
- silicone
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Not-in-force
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
- A61K8/898—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Definitions
- the present application concerns an antiperspirant aerosol composition and a packaged antiperspirant aerosol composition.
- the present inventors are primarily concerned with providing improved aerosol spray compositions. Delivery of antiperspirant actives by means of aerosol sprays may suffer from one or more of a number of disadvantages. These can include the necessity to shake the aerosol canister prior to use to achieve an adequate dispersion of active agents, "dustiness” or “powderiness” generated by particulates in the spray, visible residue on the skin and clothing, excessive cooling of the skin on application due to the rapid boiling off of propellant and, last but not least, skin irritation.
- US 5,968,489 addresses the issue of skin irritation and identifies a particular solubiliser for the antiperspirant active that may assist in achieving that objective.
- WO 03/002082 aims to reduce or solve the problems of dustiness and visible residue by solubilising the active within an anhydrous emulsion.
- compositions taught in the prior art are their unsatisfactory adherence to skin following dispensing. This can result in a large proportion of the antiperspirant active flaking or wicking off leaving only a small amount to do the job it is intended to do.
- the slightly older teaching found in US 4,806,338 does consider this matter and proposes the use of functionalised siloxanes to overcome it.
- Functionalised siloxanes proposed by US 4,806,338 can be disadvantageous, however, in that they may react with the antiperspirant active agents, either via an acid-base reaction in the case of aminofunctional silicones, which are Lewis bases (the antiperspirant actives are Lewis acids), or via a chelation reaction (in the case of the carboxy-functional silicones), which reactions can reduce the efficacy of the active.
- functional silicones of the type taught by US 4,806,338 may have reduced solubility in the aerosol propellants (and vice versa) which can give rise to inhomogeneity in the product with resultant inhomogeneity of deposition on the target site.
- an antiperspirant aerosol composition comprising antiperspirant active particulates, a propellant and at least 5% by weight of the entire antiperspirant aerosol composition of a silicone component, wherein:
- a packaged antiperspirant aerosol composition comprising a spray unit within which is comprised an antiperspirant aerosol composition according to the second aspect of the invention.
- non-volatile includes materials which have a vapor pressure of less than 0.01 mmHg (1.33322 Pa) when measured at 25°C. and have an average boiling point greater than 235°C, preferably greater than 250°C, when measured at 1 Atmosphere (0.101325 Mpa) of pressure.
- compositions referred to herein are weight percentages of the total composition (i.e. the sum of all components present) and all ratios are weight ratios.
- the present invention relates to antiperspirant aerosol compositions comprising particulate active.
- Particulate actives enhance dry feel and efficacy on skin and are thus preferred to compositions comprising solubilized active.
- bulking agents can be regarded to act by filling the void space between suspended particles.
- bulking agents include hydrophobically treated montmorillonite clay such as bentonite and/or hectorite and some silicas.
- the hectorite and bentonite clays have a layered clay structure which expands or swells on contact with polar liquids, such as water, ethanol, propylene carbonate and mixtures of these materials.
- Bulking agents can contribute to a number of perceived disadvantages, however, including residue on skin and clothing.
- the present inventors have moved away from the inclusion of bulking agents and combat the problem of active settling by including high viscosity polymeric material in the composition thus increasing the overall viscosity of the final product to reduce the settling rate.
- the present compositions comprise no solid particulates other than the antiperspirant active particles.
- antiperspirant aerosol sprays have incorporated silicones to provide lubrication and to improve the adherence of the particulate active agents to the skin.
- these silicone materials tended to be volatile silicone oils. It has now been established, however, that evaporation of the volatile oils following application can reduce the tendency of the active agents to adhere to the skin with time to a surprising degree, thereby allowing the particulates to become detached following just minor motion or abrasion by clothing not long after application. The present inventors have also learned that this tendency may be significantly reduced when non-volatile fluids are employed in place of the volatile oils - by so doing a far greater percentage of the active agent may be retained on the skin for a longer period of time to perform the task it is there to do.
- volatile silicone oils are lower in viscosity than the non-volatile fluids to the extent that compositions containing them may require additional thickening to reduce the problem of settling, discussed above. That thickening was often achieved by means of bulking agents, with the attendant disadvantages such as the formation of visible residues, also discussed above.
- non-volatile silicone fluids in place of volatile ones both objectives of improved adhesion of the active agents over time and reduction of residues may be achieved.
- Antiperspirant aerosol compositions according to the invention may advantageously comprise from 1%wt to 25%wt, preferably from 3%wt to 20%wt and more preferred from 5%wt to 15%wt antiperspirant active.
- the particulate antiperspirant active materials of this invention may comprise any compound or composition having antiperspirant activity.
- Astringent metallic salts are preferred antiperspirant materials for use herein, particularly including the inorganic and organic salts of aluminum, zirconium and zinc, and mixtures thereof.
- More preferred antiperspirant actives according to the present invention include aluminum and zirconium salts such as aluminum halides, aluminum hydroxide halides, zirconyl oxide halides, zirconyl hydroxy halides, and mixtures thereof.
- Yet more preferred are basic aluminium salts, since a number of the other types of salt, such as those of zirconium, give rise to inhalation safety concerns in an environment.
- Antiperspirant aerosol compositions according to the invention comprise at least 5% by weight of the entire antiperspirant aerosol composition of silicone component and preferably from 5 to 40%wt.
- the or each silicone comprised within the silicone component is a non-volatile silicone, as defined above.
- the antiperspirant aerosol composition more preferably comprises from 1 to 10%wt, yet more preferably from 2 to 8.5%wt and more preferably still from 3 to 6%wt silicone component.
- the antiperspirant aerosol composition may, according to another embodiment, comprise from 15 to 40%wt, yet more preferably from 20 to 35%wt and more preferably still from 25 to 35%wt silicone component.
- Silicones which may be included in the antiperspirant aerosol compositions according to the invention include silicone gums, silicone waxes and silicone oils which may be functionalised or non-functionalised, provided that they are also non-volatile, as defined herein.
- Silicone gums which may be incorporated in antiperspirant aerosol compositions according to the invention include linear silicone gums with a molecular weight from about 140,000 to 350,000 and branched-chain silicone gums having a molecular weight from 140,000 to about 2,000,000.
- Preferred silicone gums include dimethyl polysiloxane (PDMS) type gums.
- Silicone oils which may be incorporated in antiperspirant aerosol compositions according to the invention include those having a viscosity from 0.005Nsm -2 to 1000Nsm -2 (5 to 1,000,000 centipoise) measured on a Brookfield Viscometer using an appropriate spindle at the appropriate RPM range at 25°C (the RPM range and/or spindle is adjusted by a person skilled in the art according to the viscosity of the material, with highly viscous materials being measured at lower RPMs than and with different spindles from low viscosity materials. This does not affect the final viscosity reading, but is needed to keep that reading on the Viscometer scale).
- non-volatile silicone oils suitable for use in the antiperspirant compositions include, but are not limited to: Dow Corning 200, hexamethyldisiloxane, Rhodorsil Oils 70047 available from Rhone-Poulenc, Masil SF Fluid available from Mazer, Dow Corning 225, Dow Corning 1732, Dow Corning 5732, Dow Corning 5750 (available from Dow Corning Corp.); 34720, 34749, 34731 and 33134, SF-96, SF-1066 and SF18(350) Silicone Fluids (available from G. E. Silicones); Silicone L-45, Silicone L530, Silicone L-531 (available from Union Carbide) and Siloxane F-221 and Silicone Fluid SWS-101 (available from SWS Silicones).
- non-volatile silicone gums suitable for use in the antiperspirant compositions include, but are not limited to: SE30 and SE 32, both produced by GE.
- non-volatile silicone waxes suitable for use in the antiperspirant compositions include, but are not limited to 5201 and 5203, both from Dow Corning.
- Antiperspirant aerosol compositions according to the invention may comprise emollient.
- the emollient is present in an amount from 0.1%wt to 10%wt, preferably from 0.1 %wt to 5%wt and more preferred from 0.25%wt to 3.5%wt of the antiperspirant aerosol composition.
- Emollients materials may be added to enhance the feel of the products and the resulting skin feel following application.
- Emollients which may be included according to the invention include hydrocarbon oils, waxes and oil soluble vitamins.
- Suitable hydrocarbon oils according to the invention include mineral oil; suitable oil-soluble vitamins according to the invention include Vitamin E; suitable waxes according to the invention include natural and synthetic waxes.
- the class of natural waxes includes animal waxes, such as beeswax, lanolin, shellac wax and Chinese insect wax; vegetable waxes, such as carnauba, candelilla, bayberry and sugar cane; mineral waxes, such as ceresin and ozokerite; petrochemical waxes, such as microcrystalline wax and petrolatum.
- the class of synthetic waxes includes ethylenic polymers and polyol ether-esters, chlorinated naphthalenes and Fischer-Tropsch waxes.
- ethylenic polymers and polyol ether-esters, chlorinated naphthalenes and Fischer-Tropsch waxes.
- the emollients according to the invention may include silicones, such as silicone waxes. In that case, however, those silicones must be non-volatile silicones and they form part of the silicone component.
- Antiperspirant aerosol compositions according to the invention may advantageously comprise active release agents that assist the active in being released from the silicone matrix onto the skin.
- active release agents include aliphatic polyhydric alcohols having from 2 to 12 carbon atoms, examples of which include propylene glycol, ethylene glycol, diethylene glycol, butylene glycol, 1,2-proplyene glycol, 1,3-propylene glycol, 1,3-butylene glycol (1,3-butane-diol), glycerine (1,2,3-trihydroxy propane), 2-methyl-2,4-pentane-diol (hexylene glycol), 2-ethyl-1,3-hexane-diol, 1,2,6-hexanetriol, and combinations thereof.
- active release agents may be added to the composition in an amount from 0.01 %wt to 10%wt, more preferred from 0.5%wt to 7%wt and more preferably still from 1 %wt to 3%wt.
- a certain amount of bound and unbound water is associated with the antiperspirant active particulates - the precise amounts depending upon how hygroscopic that active material is.
- the levels of that water will be balanced in order that, when the particulate antiperspirant active is placed in a highly nonpolar environment (such as that found in an antiperspirant aerosol composition), agglomeration is minimised. It has been found that, by adding a quaternary ammonium functional silicones to the formulation, the agglomeration can be mitigated. Any quaternary ammonium functional silicones that is soluble in the propellant may be employed.
- the quaternary ammonium functional silicone in included in the antiperspirant aerosol composition at a level from 0.01 %wt to 25%wt, preferably from 0.1%wt to 10%wt and more preferably from 0.5%wt to 2%wt.
- Quaternary ammonium functional silicones which may be included in antiperspirant aerosol compositions according to the invention include silicone based quaternary ammonium functional silicones comprising the group: -R 1 -Z-Q 3 , where, -R 1 - is either a divalent hydrocarbon group, which may optionally incorporate ether or ester functionality, or -R 2 N(Q 1 )R 3 -, and is covalently bonded to Si in an unsupported silicone or silane; -Z- is -C(O)O- or-N(Q 2 )-; -Q 3 is -CH(R 4 )CH(OH)YN + (R 5 )(R 6 )(R 7 )X - , or a monovalent hydrocarbon group that may optionally incorporate hydroxy, diol, amide, ether or ester functionality; -R 2 - and -R 3 - are independently divalent hydrocarbon groups that may optionally incorporate ether or ester functionality; -Q 1 and -
- a preferred quaternary ammonium silicone polymer is supplied within the 5-7113 emulsion by Dow Corning and has the CAS number 495403-02-6.
- quaternary ammonium functional silicones are included in the antiperspirant aerosol compositions according to the invention, then those silicones are non-volatile silicones, as defined herein, and they form part of the silicone component.
- the propellant concentration in the antiperspirant aerosol composition may advantageously range from 20% to 90%, preferably from 40% to 85%, more preferably from about 55% to 80% by weight of the antiperspirant aerosol composition.
- the propellant comprises one or more volatile materials, which in a gaseous state, carry the other components of the present invention in particulate or droplet form.
- the aerosol propellants useful in the present invention typically have a boiling point within the range of from about -45°C to about 5°C.
- the aerosol propellants are liquefied when packaged in conventional aerosol containers under pressure. The rapid boiling of the aerosol propellant upon leaving the aerosol container aids in the atomization of the other components of the present invention.
- Aerosol propellants which may be employed in compositions according to the present invention include the chemically-inert hydrocarbons such as propane, n-butane, isobutane and cyclopropane, and mixtures thereof, as well as halogenaed hydrocarbons such as dichlorodiluoromethane (propellant 12) 1,1-dichloro-1,1,2,2-tetrafluoroethane (propellant 114), 1-chloro-1,1-difluoro-2,2-trifluoroethane (propellant 115), 1-chloro-1,1-difluoroethylene (propellant 142B), 1,1-difluoroethane (propellant 152A), dimethyl ether and monochlorodifluoromethane, and mixtures thereof.
- chemically-inert hydrocarbons such as propane, n-butane, isobutane and cyclopropane, and mixtures thereof
- the propellant incorporated into the antiperspirant aerosol composition according to the invention comprises hydrocarbons, such as isobutane, propane and butane. These materials are preferred due to their low ozone reactivity. These hydrocarbons may be used as individual components where their vapor pressures at 21.1 °C (70°F) range from 1.17 to 7.45 Bar (17 psig to 108 psig). The preferred components as individuals or mixtures range in pressure from about 1.17 to 4.83 Bar (17 to about 70 psig) and more preferably from 2.14 to 3.79 Bar (31 and 55 psig).
- hydrocarbons such as isobutane, propane and butane. These materials are preferred due to their low ozone reactivity.
- These hydrocarbons may be used as individual components where their vapor pressures at 21.1 °C (70°F) range from 1.17 to 7.45 Bar (17 psig to 108 psig).
- the preferred components as individuals or mixtures range in pressure from about 1.17 to 4.83 Bar (17 to about 70 psig
- compositions according to the invention may additionally comprise perfume, the amount depending on consumer preferences around the time of manufacture.
- compositions according to the invention may comprise from 0.05%wt to 5%wt, preferably from 0.5%wt to 3%wt and more preferably from 1 %wt to 2%wt perfume.
- packaged antiperspirant aerosol compositions comprising a spray unit within which is comprised an antiperspirant aerosol composition according to the first aspect of the invention.
- the spray unit may be any spray unit suitable for containing antiperspirant aerosol compositions according to the invention
- compositions disclosed in the below examples were all made using the following general method: silicone fluid was added under agitation to an appropriately sized container. Other silicone components (if present) were then added and the mixture was stirred until uniform. At this point, non-silicone based emollient (if present) was added and the mixture was stirred until uniform, under increased temperature (which may vary, due to differing melting points) to ensure uniformity, if appropriate. The active particulates were added to the mixture at this stage under mixing to achieve a uniform consistency. In compositions in comprising materials, such as waxes, which are not soluble in the silicone component, the temperature was maintained at an appropriate level.
- a propellant known as A46 was used, which is a mixture of 85% isobutane and 15% propane.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Description
- The present application concerns an antiperspirant aerosol composition and a packaged antiperspirant aerosol composition.
- The control of underarm wetness has been an issue of varying importance as far back as ancient Egypt and Rome, but it was not until the late 1880's that the first commercial antiperspirant products were introduced, using unbuffered zinc and aluminum compounds. Since then, many strides have been taken in this field and a wealth of antiperspirant products is now available in a wide range of delivery forms, including roll-ons, sticks and aerosol sprays.
- The present inventors are primarily concerned with providing improved aerosol spray compositions. Delivery of antiperspirant actives by means of aerosol sprays may suffer from one or more of a number of disadvantages. These can include the necessity to shake the aerosol canister prior to use to achieve an adequate dispersion of active agents, "dustiness" or "powderiness" generated by particulates in the spray, visible residue on the skin and clothing, excessive cooling of the skin on application due to the rapid boiling off of propellant and, last but not least, skin irritation.
- Prior investigators in this field have not been idle in recent years:
US 5,968,489 addresses the issue of skin irritation and identifies a particular solubiliser for the antiperspirant active that may assist in achieving that objective.WO 03/002082 - A disadvantage of compositions taught in the prior art is their unsatisfactory adherence to skin following dispensing. This can result in a large proportion of the antiperspirant active flaking or wicking off leaving only a small amount to do the job it is intended to do. The slightly older teaching found in
US 4,806,338 does consider this matter and proposes the use of functionalised siloxanes to overcome it. Functionalised siloxanes proposed byUS 4,806,338 can be disadvantageous, however, in that they may react with the antiperspirant active agents, either via an acid-base reaction in the case of aminofunctional silicones, which are Lewis bases (the antiperspirant actives are Lewis acids), or via a chelation reaction (in the case of the carboxy-functional silicones), which reactions can reduce the efficacy of the active. In addition, functional silicones of the type taught byUS 4,806,338 may have reduced solubility in the aerosol propellants (and vice versa) which can give rise to inhomogeneity in the product with resultant inhomogeneity of deposition on the target site. - It would be beneficial to provide an antiperspirant aerosol composition that can overcome the above-described disadvantages of the prior art.
- According to a first aspect of the invention, an antiperspirant aerosol composition is provided comprising antiperspirant active particulates, a propellant and at least 5% by weight of the entire antiperspirant aerosol composition of a silicone component, wherein:
- (a) the antiperspirant active particulates are the only solid particulates in the antiperspirant aerosol composition;
- (b) the silicone component comprises one or more silicones and the or each silicone is a non-volatile silicone, said silicone component comprising a quaternary ammonium functional silicone that is soluble in the propellant.
- According to a second aspect of the invention, a packaged antiperspirant aerosol composition is provided comprising a spray unit within which is comprised an antiperspirant aerosol composition according to the second aspect of the invention.
- These and other features, aspects, and advantages of the present invention will become evident to those skilled in the art from a reading of the present disclosure.
- As used herein, the term "non-volatile" includes materials which have a vapor pressure of less than 0.01 mmHg (1.33322 Pa) when measured at 25°C. and have an average boiling point greater than 235°C, preferably greater than 250°C, when measured at 1 Atmosphere (0.101325 Mpa) of pressure.
- While the specification concludes with claims which particularly point out and distinctly claim the invention, it is believed the present invention will be better understood from the following description.
- All weights, measurements and concentrations herein are measured at 25°C on the composition in its entirety, unless otherwise specified.
- Unless otherwise indicated, all percentages of compositions referred to herein are weight percentages of the total composition (i.e. the sum of all components present) and all ratios are weight ratios.
- Unless otherwise indicated, all polymer molecular weights are weight average molecular weights.
- The present invention relates to antiperspirant aerosol compositions comprising particulate active. Particulate actives enhance dry feel and efficacy on skin and are thus preferred to compositions comprising solubilized active.
- The more homogenous an antiperspirant aerosol composition is immediately prior to application, the more homogenous will be the composition actually applied to a consumer's skin and the more uniform will be the cosmetic benefit thereby achieved. Gravity can work hard to destroy homogeneity, however, by causing particulates to settle out of antiperspirant aerosol compositions. To mitigate this problem, consumers are advised to shake the spray canister before use, but this is annoying and, in cases of extreme settling, it may not be sufficient. To reduce settling, a number of approaches may be employed, such as the inclusion of so-called "bulking agents" or "suspending agents" which act by thickening the formulation and reducing the settling rate. On another level, bulking agents can be regarded to act by filling the void space between suspended particles. Examples of bulking agents include hydrophobically treated montmorillonite clay such as bentonite and/or hectorite and some silicas. The hectorite and bentonite clays have a layered clay structure which expands or swells on contact with polar liquids, such as water, ethanol, propylene carbonate and mixtures of these materials. Bulking agents can contribute to a number of perceived disadvantages, however, including residue on skin and clothing. As a result of the above-mentioned disadvantages, the present inventors have moved away from the inclusion of bulking agents and combat the problem of active settling by including high viscosity polymeric material in the composition thus increasing the overall viscosity of the final product to reduce the settling rate. In addition, to minimise settling problems altogether, the present compositions comprise no solid particulates other than the antiperspirant active particles.
- In addition to improving the consistency and reducing the dustiness of the composition, further objectives of the present inventor were improving the efficiency of the composition to ensure that as much of the active agent as possible stays at the application site and improving the cosmetics of the product by reducing residues on skin and clothes.
- Traditionally, antiperspirant aerosol sprays have incorporated silicones to provide lubrication and to improve the adherence of the particulate active agents to the skin. Historically, these silicone materials tended to be volatile silicone oils. It has now been established, however, that evaporation of the volatile oils following application can reduce the tendency of the active agents to adhere to the skin with time to a surprising degree, thereby allowing the particulates to become detached following just minor motion or abrasion by clothing not long after application. The present inventors have also learned that this tendency may be significantly reduced when non-volatile fluids are employed in place of the volatile oils - by so doing a far greater percentage of the active agent may be retained on the skin for a longer period of time to perform the task it is there to do. Furthermore, volatile silicone oils are lower in viscosity than the non-volatile fluids to the extent that compositions containing them may require additional thickening to reduce the problem of settling, discussed above. That thickening was often achieved by means of bulking agents, with the attendant disadvantages such as the formation of visible residues, also discussed above. In summary, by employing non-volatile silicone fluids in place of volatile ones both objectives of improved adhesion of the active agents over time and reduction of residues may be achieved.
- Antiperspirant aerosol compositions according to the invention may advantageously comprise from 1%wt to 25%wt, preferably from 3%wt to 20%wt and more preferred from 5%wt to 15%wt antiperspirant active.
- The particulate antiperspirant active materials of this invention may comprise any compound or composition having antiperspirant activity. Astringent metallic salts are preferred antiperspirant materials for use herein, particularly including the inorganic and organic salts of aluminum, zirconium and zinc, and mixtures thereof. More preferred antiperspirant actives according to the present invention include aluminum and zirconium salts such as aluminum halides, aluminum hydroxide halides, zirconyl oxide halides, zirconyl hydroxy halides, and mixtures thereof. Yet more preferred are basic aluminium salts, since a number of the other types of salt, such as those of zirconium, give rise to inhalation safety concerns in an environment.
- Advantageously the aluminum salts include those of the formula
Al2(OH)aClb.xH2O
wherein a is from about 2 to about 5; a+b=6; x is from about 1 to about 6; and wherein a, b, and x may have non-integer values. Particularly preferred are aluminum chlorhydroxides referred to as "5/6 basic chlorhydroxide", wherein a=5, and "2/3 basic chlorhydroxide," wherein a=4. - Antiperspirant aerosol compositions according to the invention comprise at least 5% by weight of the entire antiperspirant aerosol composition of silicone component and preferably from 5 to 40%wt. The or each silicone comprised within the silicone component is a non-volatile silicone, as defined above.
- In one advantageous embodiment, the antiperspirant aerosol composition more preferably comprises from 1 to 10%wt, yet more preferably from 2 to 8.5%wt and more preferably still from 3 to 6%wt silicone component. In some jurisdictions where strict limits are placed on the maximum amount of propellant present in the formulation, the antiperspirant aerosol composition may, according to another embodiment, comprise from 15 to 40%wt, yet more preferably from 20 to 35%wt and more preferably still from 25 to 35%wt silicone component.
- Silicones which may be included in the antiperspirant aerosol compositions according to the invention include silicone gums, silicone waxes and silicone oils which may be functionalised or non-functionalised, provided that they are also non-volatile, as defined herein.
- Silicone gums which may be incorporated in antiperspirant aerosol compositions according to the invention include linear silicone gums with a molecular weight from about 140,000 to 350,000 and branched-chain silicone gums having a molecular weight from 140,000 to about 2,000,000. Preferred silicone gums include dimethyl polysiloxane (PDMS) type gums.
- Silicone oils which may be incorporated in antiperspirant aerosol compositions according to the invention include those having a viscosity from 0.005Nsm-2 to 1000Nsm-2 (5 to 1,000,000 centipoise) measured on a Brookfield Viscometer using an appropriate spindle at the appropriate RPM range at 25°C (the RPM range and/or spindle is adjusted by a person skilled in the art according to the viscosity of the material, with highly viscous materials being measured at lower RPMs than and with different spindles from low viscosity materials. This does not affect the final viscosity reading, but is needed to keep that reading on the Viscometer scale).
- Examples of commercially available non-volatile silicone oils suitable for use in the antiperspirant compositions include, but are not limited to: Dow Corning 200, hexamethyldisiloxane, Rhodorsil Oils 70047 available from Rhone-Poulenc, Masil SF Fluid available from Mazer, Dow Corning 225, Dow Corning 1732, Dow Corning 5732, Dow Corning 5750 (available from Dow Corning Corp.); 34720, 34749, 34731 and 33134, SF-96, SF-1066 and SF18(350) Silicone Fluids (available from G. E. Silicones); Silicone L-45, Silicone L530, Silicone L-531 (available from Union Carbide) and Siloxane F-221 and Silicone Fluid SWS-101 (available from SWS Silicones).
- Examples of commercially available non-volatile silicone gums suitable for use in the antiperspirant compositions include, but are not limited to: SE30 and SE 32, both produced by GE.
- Examples of commercially available non-volatile silicone waxes suitable for use in the antiperspirant compositions include, but are not limited to 5201 and 5203, both from Dow Corning.
- Antiperspirant aerosol compositions according to the invention may comprise emollient. Advantageously, the emollient is present in an amount from 0.1%wt to 10%wt, preferably from 0.1 %wt to 5%wt and more preferred from 0.25%wt to 3.5%wt of the antiperspirant aerosol composition. Emollients materials may be added to enhance the feel of the products and the resulting skin feel following application.
- Emollients which may be included according to the invention include hydrocarbon oils, waxes and oil soluble vitamins. Suitable hydrocarbon oils according to the invention include mineral oil; suitable oil-soluble vitamins according to the invention include Vitamin E; suitable waxes according to the invention include natural and synthetic waxes. The class of natural waxes includes animal waxes, such as beeswax, lanolin, shellac wax and Chinese insect wax; vegetable waxes, such as carnauba, candelilla, bayberry and sugar cane; mineral waxes, such as ceresin and ozokerite; petrochemical waxes, such as microcrystalline wax and petrolatum. The class of synthetic waxes includes ethylenic polymers and polyol ether-esters, chlorinated naphthalenes and Fischer-Tropsch waxes. For more details, please refer to see Römpp Chemie Lexikon, Georg Thieme Verlag, Stuttgart, 9th Edition, 1995 under "Wachse".
- The emollients according to the invention may include silicones, such as silicone waxes. In that case, however, those silicones must be non-volatile silicones and they form part of the silicone component.
- Antiperspirant aerosol compositions according to the invention may advantageously comprise active release agents that assist the active in being released from the silicone matrix onto the skin. These active release agents include aliphatic polyhydric alcohols having from 2 to 12 carbon atoms, examples of which include propylene glycol, ethylene glycol, diethylene glycol, butylene glycol, 1,2-proplyene glycol, 1,3-propylene glycol, 1,3-butylene glycol (1,3-butane-diol), glycerine (1,2,3-trihydroxy propane), 2-methyl-2,4-pentane-diol (hexylene glycol), 2-ethyl-1,3-hexane-diol, 1,2,6-hexanetriol, and combinations thereof. Advantageously, active release agents may be added to the composition in an amount from 0.01 %wt to 10%wt, more preferred from 0.5%wt to 7%wt and more preferably still from 1 %wt to 3%wt.
- A certain amount of bound and unbound water is associated with the antiperspirant active particulates - the precise amounts depending upon how hygroscopic that active material is. Advantageously, the levels of that water will be balanced in order that, when the particulate antiperspirant active is placed in a highly nonpolar environment (such as that found in an antiperspirant aerosol composition), agglomeration is minimised. It has been found that, by adding a quaternary ammonium functional silicones to the formulation, the agglomeration can be mitigated. Any quaternary ammonium functional silicones that is soluble in the propellant may be employed. Advantageously the quaternary ammonium functional silicone in included in the antiperspirant aerosol composition at a level from 0.01 %wt to 25%wt, preferably from 0.1%wt to 10%wt and more preferably from 0.5%wt to 2%wt.
- Quaternary ammonium functional silicones which may be included in antiperspirant aerosol compositions according to the invention include silicone based quaternary ammonium functional silicones comprising the group: -R1-Z-Q3, where, -R1- is either a divalent hydrocarbon group, which may optionally incorporate ether or ester functionality, or -R2N(Q1)R3-, and is covalently bonded to Si in an unsupported silicone or silane; -Z- is -C(O)O- or-N(Q2)-; -Q3 is -CH(R4)CH(OH)YN+ (R5)(R6)(R7)X-, or a monovalent hydrocarbon group that may optionally incorporate hydroxy, diol, amide, ether or ester functionality; -R2- and -R3- are independently divalent hydrocarbon groups that may optionally incorporate ether or ester functionality; -Q1 and -Q2 are independently -CH(R4)CH(OH)YN+(R5)(R6)(R7)X-, or a monovalent hydrocarbon group that may optionally incorporate hydroxy, diol, amide, ether or ester functionality; Y is a divalent hydrocarbon group; R4 is a monovalent hydrocarbon group or hydrogen; R5, R6 and R7 are independently monovalent hydrocarbon groups; and X- is a counter ion, with the proviso that at least one of-Q1, -Q2 and -Q3 is -CH(R4)CH(OH)YN+(R5)(R6)(R7)X-.
- A preferred quaternary ammonium silicone polymer is supplied within the 5-7113 emulsion by Dow Corning and has the CAS number 495403-02-6.
- If quaternary ammonium functional silicones are included in the antiperspirant aerosol compositions according to the invention, then those silicones are non-volatile silicones, as defined herein, and they form part of the silicone component.
- The propellant concentration in the antiperspirant aerosol composition may advantageously range from 20% to 90%, preferably from 40% to 85%, more preferably from about 55% to 80% by weight of the antiperspirant aerosol composition.
- The propellant comprises one or more volatile materials, which in a gaseous state, carry the other components of the present invention in particulate or droplet form. The aerosol propellants useful in the present invention typically have a boiling point within the range of from about -45°C to about 5°C. The aerosol propellants are liquefied when packaged in conventional aerosol containers under pressure. The rapid boiling of the aerosol propellant upon leaving the aerosol container aids in the atomization of the other components of the present invention.
- Aerosol propellants which may be employed in compositions according to the present invention include the chemically-inert hydrocarbons such as propane, n-butane, isobutane and cyclopropane, and mixtures thereof, as well as halogenaed hydrocarbons such as dichlorodiluoromethane (propellant 12) 1,1-dichloro-1,1,2,2-tetrafluoroethane (propellant 114), 1-chloro-1,1-difluoro-2,2-trifluoroethane (propellant 115), 1-chloro-1,1-difluoroethylene (propellant 142B), 1,1-difluoroethane (propellant 152A), dimethyl ether and monochlorodifluoromethane, and mixtures thereof. Preferably, the propellant incorporated into the antiperspirant aerosol composition according to the invention comprises hydrocarbons, such as isobutane, propane and butane. These materials are preferred due to their low ozone reactivity. These hydrocarbons may be used as individual components where their vapor pressures at 21.1 °C (70°F) range from 1.17 to 7.45 Bar (17 psig to 108 psig). The preferred components as individuals or mixtures range in pressure from about 1.17 to 4.83 Bar (17 to about 70 psig) and more preferably from 2.14 to 3.79 Bar (31 and 55 psig).
- Compositions according to the invention may additionally comprise perfume, the amount depending on consumer preferences around the time of manufacture. Advantageously, at the present time, compositions according to the invention may comprise from 0.05%wt to 5%wt, preferably from 0.5%wt to 3%wt and more preferably from 1 %wt to 2%wt perfume.
- According to a second aspect of the invention, packaged antiperspirant aerosol compositions are provided, comprising a spray unit within which is comprised an antiperspirant aerosol composition according to the first aspect of the invention. The spray unit may be any spray unit suitable for containing antiperspirant aerosol compositions according to the invention
- The following examples further describe and demonstrate the preferred embodiments within the scope of the present invention. The examples are given solely for the purpose of illustration, and are not to be construed as limitations of the present invention since many variations thereof are possible without departing from its scope.
- The compositions disclosed in the below examples were all made using the following general method: silicone fluid was added under agitation to an appropriately sized container. Other silicone components (if present) were then added and the mixture was stirred until uniform. At this point, non-silicone based emollient (if present) was added and the mixture was stirred until uniform, under increased temperature (which may vary, due to differing melting points) to ensure uniformity, if appropriate. The active particulates were added to the mixture at this stage under mixing to achieve a uniform consistency. In compositions in comprising materials, such as waxes, which are not soluble in the silicone component, the temperature was maintained at an appropriate level. Lastly, the desired weight of this mixture (which may be referred to as concentrate) was transferred to the finished unit, the desired valve was affixed and propellant was added to the finished unit. A propellant known as A46 was used, which is a mixture of 85% isobutane and 15% propane.
- It is understood that the examples and specific embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to one skilled in the art without departing from the scope of the present invention.
Claims (20)
- Antiperspirant aerosol composition comprising antiperspirant active particulates, a propellant and at least 5% by weight of the entire antiperspirant aerosol composition of a silicone component, wherein:(a) the antiperspirant active particulates are the only solid particulates in the antiperspirant aerosol composition;(b) the silicone component comprises one or more silicones and the or each silicone is a non-volatile silicone, said silicone component comprising a quaternary ammonium functional silicone that is soluble in the propellant.
- Antiperspirant aerosol composition according to claim 1, comprising from 5% to 40% silicone component by weight of the antiperspirant aerosol composition.
- Antiperspirant aerosol composition according to claim 1 or 2, comprising from 5% to 10%, preferably from 6% to 8% silicone component by weight of the antiperspirant aerosol composition.
- Antiperspirant aerosol composition according to claim 1 or 2, comprising from 10% to 40%, preferably from 15% to 40%, more preferably from 25% to 35% silicone component by weight of the antiperspirant aerosol composition.
- Antiperspirant aerosol composition according to any one of the preceding claims, wherein said silicone component comprises one or more non-volatile silicone selected from silicone gums, silicone waxes and silicone oils.
- Antiperspirant aerosol composition according to claim 5, wherein silicone oils are selected from those having a viscosity from 0. 005 Nsm-2 to 1000 Nsm-2 measured at 25°C.
- Antiperspirant aerosol composition according to claim 5, wherein silicone gums are selected from the group consisting of linear silicone gums having a molecular weight from 140,000 to 350,000 and branched chain silicone gums having a molecular weight from 140,000 to 2,000,000.
- Antiperspirant aerosol composition according to any one of the preceding claims, wherein the Antiperspirant active has the following general formula: Al2(OH)aCIb. xH20 wherein a is from 2 to 5; a+b = 6; x is from 1 to 6; and wherein a, b, and x may have non-integer values.
- Antiperspirant aerosol composition according to claim 8, wherein a=5.
- Antiperspirant aerosol composition according to claim 8, wherein a=4.
- Antiperspirant aerosol composition according to any one of the preceding claims, comprising from 1 % to 25%, preferably from 3% to 20%, more preferably from 5% to 15% particulate by weight of the antiperspirant aerosol composition.
- Antiperspirant aerosol composition according to any one of the preceding claims additionally comprising emollient, preferably in an amount of from 0.1% to 10% by weight of the antiperspirant aerosol composition.
- Antiperspirant aerosol composition according to claim 12, wherein the emollient is petrolatum.
- Antiperspirant aerosol compositions according to any one of the preceding claims additionally comprising an active release agent, the active release agent comprising an aliphatic polyhydric alcohol having from 2 to 12 carbon atoms.
- Antiperspirant aerosol compositions according to claim 14, wherein active release agent comprises propylene glycol, ethylene glycol, diethylene glycol, butylene glycol, 1, 2-proplyene glycol, 1, 3-propylene glycol, 1, 3-butylene glycol, glycerine, 2-ethyl-2, 4-pentane-diol, 2-ethyl-1, 3-hexane-diol, 1,2, 6-hexanetriol or mixtures thereof.
- Antiperspirant aerosol compositions according to claim 14 or claim 15, comprising from 0.01 to 10% by weight of the antiperspirant aerosol composition of active release agent.
- Antiperspirant aerosol composition according to any of the preceding claims comprising from 0.01% to 25% by weight of the antiperspirant aerosol composition of quaternary ammonium functional silicone.
- Antiperspirant aerosol composition according to any one of the preceding claims comprising from 20% to 90%, preferably from 40% to 85%, more preferably from 55% to 80% by weight of the antiperspirant aerosol composition of propellant.
- Antiperspirant aerosol composition according to any one of the preceding claims, wherein the propellant comprises propane, n-butane, isobutane and cyclopropane, and mixtures thereof, as well as halogenated hydrocarbons such as dichlorodifluoromethane, 1,1-dichloro-1,1,2,2-tetrafluoroethane, 1-chloro-1,1-difluoro-2,2-trifluoroethane, 1-chloro-1,1-difluoroethylene, 1,1-difluoroethane, and monochlorodifluoromethane or mixtures thereof.
- Packaged antiperspirant aerosol composition comprising a spray unit within which is comprised an antiperspirant aerosol composition according to any one of the preceding claims.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54093104P | 2004-01-30 | 2004-01-30 | |
PCT/US2005/002920 WO2005074876A1 (en) | 2004-01-30 | 2005-01-27 | Antiperspirant aerosol composition |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1708674A1 EP1708674A1 (en) | 2006-10-11 |
EP1708674B1 true EP1708674B1 (en) | 2014-01-22 |
Family
ID=34837442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05712381.2A Not-in-force EP1708674B1 (en) | 2004-01-30 | 2005-01-27 | Antiperspirant aerosol composition |
Country Status (5)
Country | Link |
---|---|
US (3) | US7815899B2 (en) |
EP (1) | EP1708674B1 (en) |
CA (1) | CA2553637A1 (en) |
MX (1) | MXPA06008590A (en) |
WO (1) | WO2005074876A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102011090113A1 (en) | 2011-12-29 | 2013-07-04 | Beiersdorf Ag | Antiperspirant aerosol formulations with reduced textile staining |
WO2014043487A2 (en) | 2012-09-14 | 2014-03-20 | The Procter & Gamble Company | Aerosol antiperspirant compositions, products and methods |
US20150023886A1 (en) | 2013-07-16 | 2015-01-22 | The Procter & Gamble Company | Antiperspirant Spray Devices and Compositions |
US10766646B2 (en) | 2013-07-16 | 2020-09-08 | The Procter & Gamble Company | Antiperspirant spray devices and compositions |
US11186424B2 (en) * | 2013-07-16 | 2021-11-30 | The Procter & Gamble Company | Antiperspirant spray devices and compositions |
US10787283B2 (en) | 2013-07-16 | 2020-09-29 | The Procter & Gamble Company | Antiperspirant spray devices and compositions |
US9662285B2 (en) | 2014-03-13 | 2017-05-30 | The Procter & Gamble Company | Aerosol antiperspirant compositions, products and methods |
US9579265B2 (en) | 2014-03-13 | 2017-02-28 | The Procter & Gamble Company | Aerosol antiperspirant compositions, products and methods |
WO2016098045A1 (en) * | 2014-12-19 | 2016-06-23 | Artsana S.P.A. | Antiperspirant composition |
JP6692703B2 (en) * | 2016-06-10 | 2020-05-13 | 株式会社 資生堂 | Antiperspirant or deodorant cosmetics |
US11058616B2 (en) | 2017-12-18 | 2021-07-13 | The Procter & Gamble Company | Aerosol antiperspirant methods |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1485373A (en) * | 1973-11-08 | 1977-09-08 | Unilever Nv | Antiperspirant composition |
US4152416A (en) * | 1976-09-17 | 1979-05-01 | Marra Dorothea C | Aerosol antiperspirant compositions delivering astringent salt with low mistiness and dustiness |
US4806338A (en) * | 1985-05-30 | 1989-02-21 | The Procter & Gamble Company | Antiperspirant aerosol compositions |
US4863721A (en) * | 1987-05-22 | 1989-09-05 | The Procter & Gamble Company | Reduced stinging antiperspirant compositions |
US5069897A (en) * | 1987-10-16 | 1991-12-03 | The Proctor & Gamble Company | Antiperspirant creams |
US4904463A (en) * | 1988-03-22 | 1990-02-27 | The Procter & Gamble Company | Aerosol antiperspirant compositions |
US4935224A (en) | 1988-05-26 | 1990-06-19 | The Mennen Company | Aerosol antiperspirant composition, including substantivity fluid, capable of being dispensed at reduced spray rate, and packaged aerosol antiperspirant |
US5082652A (en) | 1989-08-22 | 1992-01-21 | Larry Mayfield | Aerosol deodorant composition and packaged aerosol deodorant |
EP0485012B1 (en) | 1990-11-08 | 1996-02-07 | The Procter & Gamble Company | Liquid antiperspirant composition |
EP0492827B1 (en) | 1990-12-21 | 1995-05-10 | Dow Corning Corporation | Encapsulated aluminum compositions |
WO1995013132A1 (en) * | 1993-11-08 | 1995-05-18 | The Gillette Company | Method of forming particles using a supercritical fluid, aerogel particles formed thereby, and antiperspirants containing aerogel particles |
CA2197444C (en) | 1994-08-17 | 2000-10-03 | Scott Edward Smith | Low propellant aerosol antiperspirant composition |
GB9506039D0 (en) * | 1995-03-24 | 1995-05-10 | Unilever Plc | Underarm compositions |
GB2299507B (en) * | 1995-04-03 | 1999-01-27 | Unilever Plc | Antiperspirant aerosol composition |
US5635165A (en) * | 1995-09-27 | 1997-06-03 | Helene Curtis, Inc. | Antiperspirant deodorant compositions |
ES2165614T3 (en) * | 1996-06-28 | 2002-03-16 | Unilever Nv | COMPOSITIONS FLUID DEODORANT / ANTITRANSPIRANT. |
US6187300B1 (en) * | 1997-12-17 | 2001-02-13 | The Procter & Gamble Company | Antiperspirant cream compositions having improved wash-off and antiperspirant efficacy |
US5968338A (en) * | 1998-01-20 | 1999-10-19 | Sachem, Inc. | Process for recovering onium hydroxides from solutions containing onium compounds |
US5968489A (en) * | 1998-05-01 | 1999-10-19 | The Procter & Gamble Company | Antiperspirant composition containing 1,2-hexanediol |
US6045784A (en) | 1998-05-07 | 2000-04-04 | The Procter & Gamble Company | Aerosol package compositions containing fluorinated hydrocarbon propellants |
US6503517B1 (en) * | 2000-01-28 | 2003-01-07 | Conopco, Inc. | Cosmetic compositions with menthol |
US6632420B1 (en) | 2000-09-28 | 2003-10-14 | The Gillette Company | Personal care product |
WO2003002082A1 (en) | 2001-06-26 | 2003-01-09 | The Procter & Gamble Company | Pressurized anhydrous antiperspirant emulsions |
DE602005024774D1 (en) | 2004-01-30 | 2010-12-30 | Procter & Gamble | ANTIPERSPIRANS-AEROSOL COMPOSITION WITH INTERNAL SILICONS |
-
2005
- 2005-01-27 CA CA002553637A patent/CA2553637A1/en not_active Abandoned
- 2005-01-27 EP EP05712381.2A patent/EP1708674B1/en not_active Not-in-force
- 2005-01-27 MX MXPA06008590A patent/MXPA06008590A/en active IP Right Grant
- 2005-01-27 WO PCT/US2005/002920 patent/WO2005074876A1/en not_active Application Discontinuation
- 2005-01-31 US US11/046,929 patent/US7815899B2/en not_active Expired - Fee Related
-
2010
- 2010-09-10 US US12/879,739 patent/US9056062B2/en not_active Expired - Fee Related
-
2015
- 2015-05-12 US US14/709,706 patent/US20150238400A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1708674A1 (en) | 2006-10-11 |
US9056062B2 (en) | 2015-06-16 |
US7815899B2 (en) | 2010-10-19 |
MXPA06008590A (en) | 2006-08-28 |
US20050169850A1 (en) | 2005-08-04 |
WO2005074876A1 (en) | 2005-08-18 |
US20150238400A1 (en) | 2015-08-27 |
CA2553637A1 (en) | 2005-08-18 |
US20100329999A1 (en) | 2010-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7951358B2 (en) | Antiperspirant aerosol composition comprising inert silicones | |
EP1708674B1 (en) | Antiperspirant aerosol composition | |
US8518384B2 (en) | Spray compositions | |
RU2517470C2 (en) | Anhydrous liquid antiperspirant/deodorant composition | |
EP0966258B2 (en) | Antiperspirant or deodorant composition | |
US20030165447A1 (en) | Topical leave-on compositions containing pantothenic acid and its derivatives to reduce the need for underarm shaving | |
WO2008114189A2 (en) | Deodorant compositions | |
EP2367521A1 (en) | Antiperspirant composition comprising mica and fatty alcohol wax | |
BR112014006289B1 (en) | ANTIPERSPIRANT COMPOSITION AND METHOD FOR REDUCING HUMAN BODY PERSPIRATION | |
ES2372175T3 (en) | ANTITRANSPIRING COMPOSITIONS CONTAINING VASELINE. | |
US20130108570A1 (en) | Antiperspirant Soft Solid Compositions Comprising A Wax Blend | |
NZ336273A (en) | Antiperspirant or deodorant compositions with moisturising cream providing occlusion or humectancy | |
US20120156152A1 (en) | Soft solid antiperspirant compositions | |
US20160206528A1 (en) | Cosmetic antiperspirants with aromatic sulphonic acids | |
US8481012B2 (en) | Antiperspirant emulsion products and processes for making antiperspirant emulsion products | |
ZA200505736B (en) | Antiperspirant actives and compositions | |
EP3041458A1 (en) | Antiperspirant compositions comprising hydroxyalkyl urea | |
EP3041457A1 (en) | Process to manufacture antiperspirant compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060616 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20101126 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20130812 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 650408 Country of ref document: AT Kind code of ref document: T Effective date: 20140215 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602005042558 Country of ref document: DE Effective date: 20140306 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20140122 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 650408 Country of ref document: AT Kind code of ref document: T Effective date: 20140122 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140522 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140522 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602005042558 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140131 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140131 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20141023 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20141208 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140127 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140324 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602005042558 Country of ref document: DE Effective date: 20141023 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140127 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140122 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20050127 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20161228 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20170131 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602005042558 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20180127 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180127 |